90 related articles for article (PubMed ID: 9417581)
21. Diabetes care needs evidence based interventions to reduce risk of vascular disease.
Byrne CD; Wild SH
BMJ; 2000 Jun; 320(7249):1554-5. PubMed ID: 10845947
[No Abstract] [Full Text] [Related]
22. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials.
Kirtane AJ; Ellis SG; Dawkins KD; Colombo A; Grube E; Popma JJ; Fahy M; Leon MB; Moses JW; Mehran R; Stone GW
J Am Coll Cardiol; 2008 Feb; 51(7):708-15. PubMed ID: 18279734
[TBL] [Abstract][Full Text] [Related]
23. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
[TBL] [Abstract][Full Text] [Related]
24. Acute myocardial infarction.
Danchin N; De Benedetti E; Urban P
Am Fam Physician; 2003 Aug; 68(3):519-21. PubMed ID: 12924835
[No Abstract] [Full Text] [Related]
25. Effect of insulin-glucose infusion on mortality following acute myocardial infarction in patients with diabetes: the diabetes and insulin-glucose infusion in acute myocardial infarction studies.
Malmberg K; Rydén L
Semin Thorac Cardiovasc Surg; 2006; 18(4):326-9. PubMed ID: 17395029
[TBL] [Abstract][Full Text] [Related]
26. Should you put all diabetic patients on statins?
Leiter LA
J Fam Pract; 2007 Apr; 56(4):294-300. PubMed ID: 17403328
[No Abstract] [Full Text] [Related]
27. [Interhospital transportation for primary angioplasty in acute myocardial infarction: not just a simple taxi ride!].
Casella G; Pavesi PC; Sangiorgio P; Bracchetti D
Ital Heart J Suppl; 2003 Jun; 4(6):502-9. PubMed ID: 19400056
[No Abstract] [Full Text] [Related]
28. The number needed to harm: is it too optimistic?
Mancini GB; Schulzer M
Can J Cardiol; 2004 Nov; 20(13):1375; author reply 1376. PubMed ID: 15612137
[No Abstract] [Full Text] [Related]
29. Improving acute coronary syndrome care: the ACC/AHA guidelines and critical pathways.
Cannon C
J Invasive Cardiol; 2003 Mar; 15 Suppl B():22B-27B; discussion 27B-29B. PubMed ID: 12724583
[No Abstract] [Full Text] [Related]
30. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.
Mellbin LG; Malmberg K; Norhammar A; Wedel H; Rydén L;
Eur Heart J; 2008 Jan; 29(2):166-76. PubMed ID: 18156614
[TBL] [Abstract][Full Text] [Related]
31. Who does not need a statin: too late in end-stage renal disease or heart failure?
Laufs U; Custodis F; Böhm M
Postgrad Med J; 2009 Apr; 85(1002):187-9. PubMed ID: 19417167
[TBL] [Abstract][Full Text] [Related]
32. [Coronary artery surgery in patients with diabetes mellitus].
Lauruschkat AH; Ennker J
Dtsch Med Wochenschr; 2002 Feb; 127(8):381-3. PubMed ID: 11859447
[No Abstract] [Full Text] [Related]
33. [Type 2 diabetes mellitus and coronary heart disease].
Brändle M; Amann FW; Salomon F
Schweiz Med Wochenschr; 1999 May; 129(18):700-6. PubMed ID: 10407943
[TBL] [Abstract][Full Text] [Related]
34. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial.
Serebruany VL; Malinin AI; Pokov A; Barsness G; Hanley DF
Am Heart J; 2008 Jan; 155(1):93.e1-7. PubMed ID: 18082496
[TBL] [Abstract][Full Text] [Related]
35. [Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication].
Gustafsson I; Malmberg K; Rydén L; Wedel H; Birkeland K; Bootsma A; Dickstein K; Efendic S; Fisher M; Hamsten A; Herlitz J; Hildebrandt PR; MacLeod K; Laakso M; Torp-Pedersen CT; Waldenström A;
Ugeskr Laeger; 2006 Feb; 168(6):581-4. PubMed ID: 16476220
[TBL] [Abstract][Full Text] [Related]
36. Rationale for the use of insulin therapy alone as the pharmacological treatment of type 2 diabetes.
Berger M; Jörgens V; Mühlhauser I
Diabetes Care; 1999 Apr; 22 Suppl 3():C71-5. PubMed ID: 10189566
[TBL] [Abstract][Full Text] [Related]
37. Aspirin in type 2 diabetes: is there any evidence base?
Walsh M; Spurling G
BMJ; 2008 Oct; 337():a1902. PubMed ID: 18927174
[No Abstract] [Full Text] [Related]
38. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
[TBL] [Abstract][Full Text] [Related]
39. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
[TBL] [Abstract][Full Text] [Related]
40. [What does the FRISC II study say about the treatment of unstable coronary disease, especially non-Q-wave myocardial infarction?].
Mickley H
Ugeskr Laeger; 2001 Jan; 163(3):305-7. PubMed ID: 11219113
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
